Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma

Published:2018-11-19 Issue:1 Volume:25 Page:119-129
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Agarwal Rishu^ORCID,Chan Yih-Chih^ORCID,Tam Constantine S.,Hunter Tane,Vassiliadis Dane,Teh Charis E.,Thijssen Rachel,Yeh Paul,Wong Stephen Q.,Ftouni Sarah,Lam Enid Y. N.,Anderson Mary Ann,Pott Christiane,Gilan Omer,Bell Charles C.,Knezevic Kathy,Blombery Piers,Rayeroux Kathleen,Zordan Adrian,Li Jason,Huang David C. S.,Wall Meaghan^ORCID,Seymour John F.,Gray Daniel H. D.^ORCID,Roberts Andrew W.^ORCID,Dawson Mark A.^ORCID,Dawson Sarah-Jane^ORCID

Funder

Leukemia and Lymphoma Society

Leukaemia Foundation

Howard Hughes Medical Institute

Department of Health | National Health and Medical Research Council

Mark A Dawson

Haematology Society of Australia and New Zealand

Rishu Agarwal

Maddie Riewoldt's Vision

Yih-Chih Chan

Constantine S Tam

Tane Alexander Hunter

Dane Vassiliadis

Paul S Yeh

Stephen Q Wong

Sarah Ftouni

Enid Lam

Christiane Pott

Omer Gilan

Charles C Bell

Jason Li

David Huang

John F Seymour

Andrew W. Roberts

Sarah-Jane Dawson

Charis Teh

Rachel Thijssen

Snowdome Foundation

Mary Ann Anderson

Kathy Knezevic

Piers Blombery

Kathleen Rayeroux

Adrian Zordan

Meaghan Wall

Daniel Gray

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-018-0243-z.pdf

Reference58 articles.

1. Cheah, C. Y., Seymour, J. F. & Wang, M. L. Mantle cell lymphoma. J. Clin. Oncol. 34, 1256–1269 (2016).

2. Le Gouill, S. et al. Rituximab after autologous stem-cell transplantation in mantle-cell lymphoma. N. Engl. J. Med. 377, 1250–1260 (2017).

3. Martin, P., Ruan, J. & Leonard, J. P. The potential for chemotherapy-free strategies in mantle cell lymphoma. Blood 130, 1881–1888 (2017).

4. Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202–208 (2013).

5. Wang, M. L. et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369, 507–516 (2013).

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma;Journal of Experimental Medicine;2024-09-05

2. Clinical applications of circulating tumor DNA in hematological malignancies: From past to the future;Blood Reviews;2024-09

3. Ready, AIM, stop: ibrutinib plus venetoclax in MCL;Blood;2024-08-22

4. Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions;Blood;2024-08-22

5. Dialog between mantle cell lymphoma cells and lymphoma-associated macrophages underlies ibrutinib resistance;Journal of Advanced Research;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3